Lp(a) Tied to Higher CVD Events; Risk Reduction With IPE : v

New analysis of the REDUCE-IT trial suggested benefit of icosapent ethyl doesn't vary by Lp(a) level and confirmed risk for Lp(a) with high triglycerides but not cholesterol.

Related Keywords

Colorado , United States , Harpreets Bhatia , Michael Szarek , Michaelj Blaha , Department Of Cardiology , American College Of Cardiology , Johns Hopkins Ciccarone Center , Journal Of The American College Cardiology , University Of Colorado , University Of California San Diego , Division Of Cardiovascular Medicine , American College , Scientific Session , Atherosclerotic Cardiovascular Disease , Cardiovascular Medicine , California San Diego , Lipids , Ipid Management , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Interprofessional , Interprofessional Collaboration , Interprofessional Team , Health Care Team , Eam Based Care Teamwork Collaborative Practice , Interprofessional Education , Interprofessional Continuing Education , Interprofessional Practice , Pce , Tape , Triglycerides ,